HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx

AIDS Research and Human Retroviruses

Volumn 30, Issue 2, 2014, Pages 195-203

  Bloch, Nicolin ^a   O'Brien, Meagan ^a   Norton, Thomas D ^a   Polsky, Sylvie B ^a   Bhardwaj, Nina ^a,b   Landau, Nathaniel R ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLIN DEPENDENT KINASE 1; GAG PROTEIN; INTERFERON; PHOSPHATASE; STERILE ALPHA MOTIF AND HD DOMAIN 1 PROTEIN; UNCLASSIFIED DRUG; VIRION PACKAGED ACCESSORY PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; MYELOID DENDRITIC CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRION; VIRUS RESISTANCE;

CELLS, CULTURED; DENDRITIC CELLS; HIV-1; HUMANS; MONOMERIC GTP-BINDING PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84893463287     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0119     Document Type: Article

References (48)

1. Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179(4):1109-1118.
2. Zhou LJ and Tedder TF: CD14 + blood monocytes can differentiate into functionally mature CD83 + dendritic cells. Proc Natl Acad Sci USA 1996;93(6):2588-2592.
3. McKenna K, Beignon AS, and Bhardwaj N: Plasmacytoid dendritic cells: Linking innate and adaptive immunity. J Virol 2005;79(1):17-27.
4. Fonteneau JF, Larsson M, Beignon AS, et al.: Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 2004;78(10): 5223-5232.
5. O'Brien M, Manches O, Sabado RL, et al.: Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-Alpha-producing and partially matured phenotype. J Clin Invest 2011;121(3): 1088-1101.
6. Bosinger SE, Li Q, Gordon SN, et al.: Global genomic analysis reveals rapid control of a robust innate response in SIVinfected sooty mangabeys. J Clin Invest 2009;119(12):3556-3572
7. Jacquelin B, Mayau V, Targat B, et al.: Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009;119(12):3544-3555.
8. Fernandez S, Tanaskovic S, Helbig K, et al.: CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferonstimulated genes in CD4 + T cells. J Infect Dis 2011;204(12): 1927-1935.
9. Manches O, Munn D, Fallahi A, et al.: HIV-Activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest 2008; 118(10):3431-3439.
10. Manches O, Fernandez MV, Plumas J, Chaperot L, and Bhardwaj N: Activation of the noncanonical NF-kappaB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc Natl Acad Sci USA 2012;109(35):14122-14127
11. Li Q, Estes JD, Schlievert PM, et al.: Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009;458(7241): 1034-1038.
12. Hardy AW, Graham DR, Shearer GM, and Herbeuval JP: HIV turns plasmacytoid dendritic cells (pDC) into TRAILexpressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-Alpha. Proc Natl Acad Sci USA 2007;104(44):17453-17458.
13. Fong L, Mengozzi M, Abbey NW, Herndier BG, and Engleman EG: Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J Virol 2002;76(21):11033-11041.
14. Wu L and KewalRamani VN: Dendritic-cell interactions with HIV: Infection and viral dissemination. Nat Rev Immunol 2006;6(11):859-868.
15. Sabado RL, O'Brien M, Subedi A, et al.: Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010;116(19):3839-3852.
16. Laguette N, Sobhian B, Casartelli N, et al.: SAMHD1 is the dendritic-And myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011;474(7353):654-657.
17. Hrecka K, Hao C, Gierszewska M, et al.: Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011;474(7353):658-661.
18. Powell RD, Holland PJ, Hollis T, and Perrino FW: Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem 2011;286(51):43596-43600.
19. Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al.: HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011;480(7377):379-382.
20. Lahouassa H, Daddacha W, Hofmann H, et al.: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012;13(3):223-228.
21. White TE, Brandariz-Nunez A, Carlos Valle-Casuso J, et al.: Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 2013; 436(1):81-90.
22. Gramberg T, Kahle T, Bloch N, et al.: Restriction of diverse retroviruses by SAMHD1. Retrovirology 2013;10:26.
23. Hollenbaugh JA, Gee P, Baker J, et al.: Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog 2013;9(6):e1003481.
24. Baldauf HM, Pan X, Erikson E, et al.: SAMHD1 restricts HIV-1 infection in resting CD4( + ) T cells. Nat Med 2012; 18(11):1682-1687.
25. Descours B, Cribier A, Chable-Bessia C, et al.: SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4( + ) T-cells. Retrovirology 2012;9:87.
26. White TE, Brandariz-Nunez A, Valle-Casuso JC, et al.: The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013;13(4): 441-451.
27. Cribier A, Descours B, Valadao AL, Laguette N, and Benkirane M: Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 2013;3(4):1036-1043.
28. Mangeot PE, Duperrier K, Negre D, et al.: High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 2002;5(3):283-290.
29. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, and Emerman M: The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 2012;11(2):194-204.
30. Laguette N, Rahm N, Sobhian B, et al.: Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 2012;11(2):205-217.
31. Sharova N, Wu Y, Zhu X, et al.: Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 2008;4(5):e1000057.
32. Srivastava S, Swanson SK, Manel N, Florens L, Washburn MP, Skowronski J: Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog 2008; 4(5):e1000059.
33. Hofmann H, Logue EC, Bloch N, et al.: The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J Virol 2012;86(23):12552-12560.
34. Brandariz-Nunez A, Valle-Casuso JC, White TE, et al.: Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology 2012;9:49.
35. Goujon C, Riviere L, Jarrosson-Wuilleme L, et al.: SIVSM/ HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 2007;4:2.
36. Sunseri N, O'Brien M, Bhardwaj N, and Landau NR: Human immunodeficiency virus type 1 modified to package simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J Virol 2011;85(13):6263-6274.
37. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, and Littman DR: A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010;467(7312): 214-217.
38. Beignon AS, McKenna K, Skoberne M, et al.: Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005;115(11): 3265-3275.
39. Campeau E, Ruhl VE, Rodier F, et al.: A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009;4(8):e6529.
40. Bobadilla S, Sunseri N, and Landau NR: Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther 2013;20(5):514-520.
41. Bennett EJ, Rush J, Gygi SP, and Harper JW: Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell 2010;143(6):951-965.
42. Petroski MD and Deshaies RJ: Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005;6(1):9-20.
43. Berger A, Sommer AF, Zwarg J, et al.: SAMHD1-deficient CD14 + cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog 2011;7(12):e1002425.
44. Cuadrado E, Jansen MH, Anink J, et al.: Chronic exposure of astrocytes to interferon-Alpha reveals molecular changes related to Aicardi-Goutieres syndrome. Brain 2013;136 (Pt 1):245-258.
45. Dragin L, Anh Nguyen L, Lahouassa H, et al.: Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply. Retrovirology 2013;10(1):30.
46. Dewhurst S, Bresser J, Stevenson M, Sakai K, Evinger-Hodges MJ, and Volsky DJ: Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). FEBS Lett 1987;213(1):138-143.
47. Wiley CA, Schrier RD, Nelson JA, Lampert PW, and Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83(18):7089-7093.
48. Geijtenbeek TB, Kwon DS, Torensma R, et al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100(5):587-597.